Member Info for Louis_Winthorp

Complacency through the money in the bank.

Lack of ambition to actually threaten to be what Mullis proclaimed as what he wanted Novacyt to be.

It has a feel of a company that likes to be in its comfort zone and doesn't want to make moves to extend itself.

Prove us wrong, Novacyt.

Well, they don't appear to be pulling much in from those large players or they would've had plenty to tell us over the last 20 months.

https://thebiomedicalscientist.net/

There you go Novacyt... we know you read the board.

I wouldn't be surprised if they didn't even know about about this publication.

Is it a paper magazine as well as an online thing?

There was a GP on the BBC programme Morning Live at Christmas. She said that current testing would be swabs and sent away for result and not quick enough.

Novacyt really should be pushing this.

Don't encourage 'em!

I normally never take the DM seriously but this me lol at the thought!

https://www.dailymail.co.uk/news/article-11494595/Vladimir-Putin-fell-stairs-home-soiled-himself.html

Hopefully the puffy faced old c... will break his neck next time!

*tears of laughter emoji*

70.3 million shares in issue and highest price I saw at peak was £12.50ish. So, £850m market cap... but not for long as it dropped back in to the £11 - 10 range pretty quickly after the highs.

LYG.... products due for release were non Covid products.

Don't be so hung up on Covid!

*winky emoji*

Hopefully NCYT won't become a company that starts missing self stated timelines for new product releases that the market was given a heads up on in the Summer.

Also, I hope these products are RNS'd and not sneaked out on Twitter and other social media platforms.

Perhaps they could the use the publication that Poidster mentioned which is industry known and a good tool to publicize, apparently... *and which I can't remember what it is called at the moment! :-)

*In my defence, I am not in the industry!

Trade it then.

Enter RazzaB. Leaves pointless message. Gets zero interaction. Leaves feeling lower than when he posted. REPEAT

Look familiar?

*grinning emoji*

I've been here since Jan Nelson days, when XTR was being ramped as the AIM darling of late 2014 - early 15.

Still waiting... to stubborn to sell...

Ignore the last post...

What happened to the loony posts?

I had a look later in the day and he was gone... progress!

They still do read this board then...

If I had a wife and I told her I loved her, she would probably say, "What price is that fücking NCYT now??"

*frown emoji*

£54 was one person's narrative.

If anybody bought in here on that... well....

In early 2021, £15-20 was only a decent forward looking statement away... so near but yet so far.

I never thought I'd say this as I never thought we would ever see the share price and sentiment erosion that we have seen over the last 18 months.

It still looks like a company scared of success and happy to stay smalltime. Poidsters post earlier is a sad indictment on the lack of NCYT putting itself out there. Add that to the perceived toothless approach with regards the dispute.

I guess we will hear about the new products that were set to be launched in Q4 (we are halfway through it now) on Twitter... something to look forward to...

This has turned in to a real 'what could've been'.

Maybe they don't even know of its existence... I didn't?! Good call, Poidster!

Perhaps someone in the marketing department could take 10 minutes and get in touch with The Biomedical Scientist magazine and put NCYT in the relevant shop window??

https://thebiomedicalscientist.net/media-pack